Can erythropoietin eradicate red cell transfusions in the critically ill?*
Authors:
- Paul C. HébertPHPaul C. Hébert
- Dean A. FergussonDFDean A. Fergusson
- 1 September 2006
- journal article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 34 (9) , 2490-2491
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: A randomized, double-blind, placebo-controlled trial*Critical Care Medicine, 2006
- The CRIT Study: Anemia and blood transfusion in the critically ill—Current clinical practice in the United States*Critical Care Medicine, 2004
- Efficacy of Recombinant Human Erythropoietin in Critically Ill PatientsJAMA, 2002
- Anemia and Blood Transfusion in Critically Ill PatientsJAMA, 2002
- Nutritional deficiencies and blunted erythropoietin response as causes of the Amemia of critical illnessJournal of Critical Care, 2001
- Anemia of the critically ill: “Acute” anemia of chronic diseaseCritical Care Medicine, 2000
- Efficacy of recombinant human erythropoietin in the critically ill patient: A randomized, double-blind, placebo-controlled trialCritical Care Medicine, 1999
- Proinflammatory Cytokines Lowering Erythropoietin ProductionJournal of Interferon & Cytokine Research, 1998
- High-Dose Recombinant Human Erythropoietin Stimulates Reticulocyte Production in Patients with Multiple Organ Dysfunction SyndromeThe Journal of Trauma: Injury, Infection, and Critical Care, 1998
- Erythropoietin response is blunted in critically ill patientsIntensive Care Medicine, 1997